AKCEA THERAPEUTICS INC's ticker is AKCA and the CUSIP is 00972L107. A total of 45 filers reported holding AKCEA THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $1,191,000 | -35.7% | 70,286 | -41.6% | 0.05% | -37.5% |
| Q3 2019 | $1,851,000 | -34.4% | 120,286 | 0.0% | 0.08% | -38.9% |
| Q2 2019 | $2,821,000 | +98.0% | 120,286 | +139.2% | 0.13% | +98.5% |
| Q1 2019 | $1,425,000 | -37.2% | 50,286 | -33.2% | 0.07% | -39.4% |
| Q4 2018 | $2,269,000 | -32.0% | 75,286 | -21.0% | 0.11% | -27.8% |
| Q3 2018 | $3,337,000 | -28.8% | 95,286 | -51.8% | 0.15% | -18.4% |
| Q2 2018 | $4,690,000 | -2.5% | 197,800 | +5.3% | 0.18% | -4.6% |
| Q1 2018 | $4,810,000 | +84.7% | 187,800 | +25.2% | 0.19% | +94.0% |
| Q4 2017 | $2,604,000 | -24.7% | 150,000 | +20.0% | 0.10% | -23.7% |
| Q3 2017 | $3,459,000 | – | 125,000 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Iguana Healthcare Management, LLC | 100,000 | $1,736,000 | 1.13% |
| BB BIOTECH AG | 1,248,650 | $21,677,000 | 0.61% |
| Virtus ETF Advisers LLC | 18,071 | $314,000 | 0.39% |
| Eventide Asset Management | 420,000 | $7,291,000 | 0.38% |
| Granahan Investment Management | 194,376 | $3,374,000 | 0.26% |
| ALTRINSIC GLOBAL ADVISORS LLC | 150,000 | $2,604,000 | 0.10% |
| Candriam S.C.A. | 114,571 | $1,990,000 | 0.03% |
| ARDSLEY ADVISORY PARTNERS LP | 15,000 | $260,000 | 0.03% |
| Delpha Capital Management, LLC | 1,521 | $26,000 | 0.03% |
| FMR LLC | 9,981,244 | $173,274,000 | 0.02% |